Michael J Schwartz

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Venues

Cancers

This page only lists publications with an associated author ORCID identifier.

Publications

Arvin K George, Ranko Miocinovic, Amit R Patel, Derek J Lomas, Andres F Correa, David Y T Chen, Ardeshir R Rastinehad, Michael J Schwartz, Edward M Uchio, Abhinav Sidana, Brian T Helfand, Jeffrey C Gahan, Alice Yu, Srinivas Vourganti, Al Baha Barqawi, Wayne G Brisbane, James S Wysock, Thomas J Polascik, Timothy D McClure, Jonathan A Coleman
A Description and Safety Overview of Irreversible Electroporation for Prostate Tissue Ablation in Intermediate-Risk Prostate Cancer Patients: Preliminary Results from the PRESERVE Trial. Cancers 16 (12) (2024)
Arvin K George, Ranko Miocinovic, Amit R Patel, Derek J Lomas, Andres F Correa, David Y T Chen, Ardeshir R Rastinehad, Michael J Schwartz, Edward M Uchio, Abhinav Sidana, Brian T Helfand, Jeffrey C Gahan, Alice Yu, Srinivas Vourganti, Al Baha Barqawi, Wayne G Brisbane, James S Wysock, Thomas J Polascik, Timothy D McClure, Jonathan A Coleman
A Description and Safety Overview of Irreversible Electroporation for Prostate Tissue Ablation in Intermediate-Risk Prostate Cancer Patients: Preliminary Results from the PRESERVE Trial. Cancers 16 (12) (2024)
Arvin K George, Ranko Miocinovic, Amit R Patel, Derek J Lomas, Andres F Correa, David Y T Chen, Ardeshir R Rastinehad, Michael J Schwartz, Edward M Uchio, Abhinav Sidana, Brian T Helfand, Jeffrey C Gahan, Alice Yu, Srinivas Vourganti, Al Baha Barqawi, Wayne G Brisbane, James S Wysock, Thomas J Polascik, Timothy D McClure, Jonathan A Coleman
A Description and Safety Overview of Irreversible Electroporation for Prostate Tissue Ablation in Intermediate-Risk Prostate Cancer Patients: Preliminary Results from the PRESERVE Trial. Cancers 16 (12) (2024)

Michael J Schwartz.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Michael J Schwartz